Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients-Reference-Cited by-同舟云学术

Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients

Published:2022-03-19 Issue:3 Volume:11 Page:1147-1161
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Namba Kenichi^ORCID,Kaburaki Toshikatsu,Tsuruga Hidekazu,Ogawa Yohei,Iwashita Eri,Goto Hiroshi

Funder

AbbVie GK

Eisai

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s40123-022-00493-z.pdf

Reference40 articles.

1. Sonoda KH, Hasegawa E, Namba K, et al. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021;65(2):184–90.

2. Lee RW, Dick AD. Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye (Lond). 2012;26(1):17–28.

3. Rossi DC, Ribi C, Guex-Crosier Y. Treatment of chronic non-infectious uveitis and scleritis. Swiss Med Wkly. 2019;149:w20025.

4. Castiblanco C, Foster CS. Review of systemic immunosuppression for autoimmune uveitis. Ophthalmol Ther. 2014;3(1–2):17–36.

5. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the Use of Glucocorticoids and Biological Agents in Non-Infectious Uveitis;Journal of Biosciences and Medicines;2024

2. Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet’s disease-related uveitis: a case report;Journal of Ophthalmic Inflammation and Infection;2023-11-28

3. Successful Remission with Upadacitinib in Two Patients with Anti-TNF-Refractory Macular Edema Associated with Behçet’s Uveitis;Ocular Immunology and Inflammation;2023-10-06

4. Intravitreal dexamethasone implants facilitate the management of refractory Behçet's uveitis with vasculitis;Clinical Immunology;2023-06

5. Risk of uveitis in patients with psoriasis in Korea: A nationwide population‐based cohort study;Journal of the European Academy of Dermatology and Venereology;2023-04-03